Currently holds a position at Supernus Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
President, Chief Executive Officer, Secretary, Director | Supernus Pharmaceuticals Inc | Jan. 1, 2005 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-02-06 | 2023-02-02 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
13,532
-1.7%
42.06569,088 USD |
13,532 -1.7% | 42.06 | 569,088 USD | |
2023-02-03 | 2023-02-01 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
300
-0.0%
42.0112,602 USD |
300 -0.0% | 42.01 | 12,602 USD | |
2023-02-02 | 2023-01-31 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
976
-0.1%
42.0141,002 USD |
976 -0.1% | 42.01 | 41,002 USD | |
2023-01-20 | 2023-01-18 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
4,936
-0.6%
40.40199,394 USD |
4,936 -0.6% | 40.40 | 199,394 USD | |
2023-01-19 | 2023-01-17 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
25,446
-3.1%
40.031,018,728 USD |
25,446 -3.1% | 40.03 | 1,018,728 USD | |
2022-12-22 | 2022-12-21 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
11,354
-1.4%
38.14433,070 USD |
11,354 -1.4% | 38.14 | 433,070 USD | |
2022-12-22 | 2022-12-20 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
4,006
-0.5%
38.02152,317 USD |
4,006 -0.5% | 38.02 | 152,317 USD | |
2022-11-28 | 2022-11-25 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
11,135
-1.4%
35.18391,685 USD |
11,135 -1.4% | 35.18 | 391,685 USD | |
2022-11-28 | 2022-11-23 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
2,259
-0.3%
35.0579,189 USD |
2,259 -0.3% | 35.05 | 79,189 USD | |
2022-11-23 | 2022-11-22 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
600
-0.1%
35.0021,001 USD |
600 -0.1% | 35.00 | 21,001 USD | |
2022-11-22 | 2022-11-21 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
531
-0.1%
35.0118,592 USD |
531 -0.1% | 35.01 | 18,592 USD | |
2022-11-17 | 2022-11-15 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
1,115
-0.1%
35.0039,028 USD |
1,115 -0.1% | 35.00 | 39,028 USD | |
2022-08-18 | 2022-08-16 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
14,690
-1.9%
34.01499,651 USD |
14,690 -1.9% | 34.01 | 499,651 USD | |
2022-08-17 | 2022-08-15 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
17,302
-2.2%
34.03588,752 USD |
17,302 -2.2% | 34.03 | 588,752 USD | |
2022-08-11 | 2022-08-10 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
28,437
-3.7%
31.22887,803 USD |
28,437 -3.7% | 31.22 | 887,803 USD | |
2022-08-10 | 2022-08-09 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
39,431
-5.2%
31.151,228,276 USD |
39,431 -5.2% | 31.15 | 1,228,276 USD | |
2022-08-09 | 2022-08-08 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
10,032
-1.4%
32.11322,128 USD |
10,032 -1.4% | 32.11 | 322,128 USD | |
2022-08-09 | 2022-08-08 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
107,875
-13.2%
31.403,387,275 USD |
107,875 -13.2% | 31.40 | 3,387,275 USD | |
2021-12-06 | 2021-12-03 |
scPharmaceuticals Inc
(SCPH)
|
B Purchase |
5,000
+inf%
3.9119,569 USD |
5,000 +inf% | 3.91 | 19,569 USD |